This TikTok about NAD+ supplements needs major context
Quick answer
NAD+ declines with age and plays a documented role in mitochondrial function, sirtuin activation, and DNA repair, making it a legitimate area of longevity research. The creator's dismissal of all oral supplementation ignores well-studied precursors like NMN and NR, which have demonstrated the ability to raise systemic NAD+ levels in published human trials. Claims about subcutaneous NAD+ providing "100% bioavailability" and resolving neurological decay or complete inflammation are not supported by current peer-reviewed human clinical data.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @drtrevorbachmeyer actually say?
The short version: NAD+ is essential for ATP production, oral NAD+ supplements are "a scam" with "zero bioavailability," and subcutaneous injection gives "100% bioavailability." He also claimed low NAD+ causes brain fog he called "early stage neurological decay," muscle loss, immune dysfunction, fat storage, and poor blood sugar control. He ended with a promise that replenishing NAD+ delivers a "system-wide operating system recalibration."
The biochemistry framing is mostly real. NAD+ does act as an electron acceptor at multiple points in cellular energy metabolism, including glycolysis, the pyruvate dehydrogenase complex, and the citric acid cycle. Sirtuins are a legitimate family of NAD+-dependent deacylases involved in DNA repair and mitochondrial regulation. None of that is invented. The problem is what gets layered on top of the solid foundation.
Does the science back this up?
Partially, and with significant caveats. The oral bioavailability claim is the loudest in the video, and it is also where the evidence gets messy in ways the creator ignores.
NAD+ itself does have poor oral bioavailability because it is degraded in the gut before absorption. But precursors, specifically nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), survive digestion and effectively raise blood NAD+ levels. Conze et al. (2019, Scientific Reports) showed oral NR raised whole-blood NAD+ in a dose-dependent manner. Yoshino et al. (2021, Science) found oral NMN improved muscle insulin sensitivity in postmenopausal women. Calling oral supplementation "a scam" while ignoring precursors entirely is a selective reading of the literature.
On the injection side, intravenous NAD+ infusions do raise NAD+ levels effectively, and subcutaneous delivery is being studied, but "100% bioavailability" for subcutaneous NAD+ is not an established figure in published literature. That specific number appears to be asserted rather than sourced.
What did they get wrong (or right)?
Credit where it is due: the metabolic biochemistry is largely accurate. NAD+ depletion with age is real and well-documented. Verdin (2015, Science) reviewed evidence that NAD+ declines significantly in aging tissues and linked that decline to mitochondrial dysfunction and sirtuin activity reduction. That part of the video is grounded.
What crossed the line:
- "Zero bioavailability" for oral NAD+ ignores the entire NR and NMN precursor literature. This is not a nuance. It is a major omission that serves a commercial framing.
- "Early stage neurological decay" as a label for brain fog is a significant overclaim. Brain fog has many causes. Connecting low NAD+ to amyloid plaques and tau tangles in a TikTok video, without citing human clinical trial data supporting that causal chain, is misleading.
- "100% bioavailability" for subcutaneous NAD+ is stated as established physiology. It is not confirmed in published pharmacokinetic studies for subcutaneous administration specifically.
- The claim that injected NAD+ makes inflammation "dissipate completely" is not supported by any trial showing complete resolution of systemic inflammation from NAD+ alone.
What should you actually know?
NAD+ biology is genuinely interesting and the research is active. Aging does reduce NAD+ levels, and restoring them shows promise in animal models and some early human trials. But the gap between "promising research" and "system-wide recalibration" is enormous, and this video jumps it without a net.
If you are interested in NAD+ support, the oral precursor data is more robust than this video admits. Martens et al. (2023, Nature Aging) found NMN supplementation improved walking speed and other functional measures in older adults. That is a real, peer-reviewed finding, not a scam. Injectable NAD+ and its precursors are being explored, but the clinical evidence base for subcutaneous delivery specifically is still thin compared to IV administration studied in clinical settings.
Anyone considering injectable NAD+ should have that conversation with a licensed provider who can review their individual health status. This video does not replace that evaluation, regardless of how confident the delivery is.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
NAD+ Peptide Complex access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For This TikTok about NAD+ supplements needs major context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
NAD+ Peptide Complex is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this nad+ video claims cluster
Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.
Claim verdict
The useful answer behind this video
Claim being checked
NAD+ declines with age and plays a documented role in mitochondrial function, sirtuin activation, and DNA repair, making it a legitimate area of longevity research.
FormBlends verdict
NAD+ declines with age and plays a documented role in mitochondrial function, sirtuin activation, and DNA repair, making it a legitimate area of longevity research. The creator's dismissal of all oral supplementation ignores well-studied precursors like NMN and NR, which have demonstrated the ability to raise systemic NAD+ levels in published human trials. Claims about subcutaneous NAD+ providing "100% bioavailability" and resolving neurological decay or complete inflammation are not supported by current peer-reviewed human clinical data.
Patient-safe next step
Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- NAD+ declines with age and plays a documented role in mitochondrial function, sirtuin activation, and DNA repair, making it a legitimate area of longevity research. The creator's dismissal of all oral supplementation ignores well-studied precursors like NMN and NR, which have demonstrated the ability to raise systemic NAD+ levels in published human trials. Claims about subcutaneous NAD+ providing "100% bioavailability" and resolving neurological decay or complete inflammation are not supported by current peer-reviewed human clinical data.
- NAD+ levels do decline with age: Verdin (2015, Science) documented this in aging tissues and linked it to reduced mitochondrial function and sirtuin activity.
- Oral NMN raised walking speed and functional measures in older adults in Martens et al. (2023, Nature Aging), directly contradicting the 'oral is a scam' claim.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.
Review NAD+ Peptide ComplexWhat You'll Learn
- NAD+ levels do decline with age: Verdin (2015, Science) documented this in aging tissues and linked it to reduced mitochondrial function and sirtuin activity.
- Oral NMN raised walking speed and functional measures in older adults in Martens et al. (2023, Nature Aging), directly contradicting the 'oral is a scam' claim.
- NR supplementation raised whole-blood NAD+ in a dose-dependent manner in Conze et al. (2019, Scientific Reports), a peer-reviewed finding the video ignores entirely.
- The '100% bioavailability' figure for subcutaneous NAD+ is not sourced in published pharmacokinetic literature and should be treated as an unverified marketing claim.
- Connecting brain fog to amyloid plaques and tau tangles via NAD+ depletion is a speculative mechanistic leap, not an established clinical finding in humans.
- Sirtuins are real NAD+-dependent enzymes with documented roles in DNA repair and inflammation regulation, so the core biochemistry in the video is not invented.
- Anyone considering injectable NAD+ therapy should consult a licensed provider: current human clinical trials for subcutaneous delivery specifically are limited compared to IV protocols studied in controlled settings.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr Trevor Bachmeyer · TikTok creator
19.2K views on this video
NAD+ let’s talk about it quickly Comment “ENGINE” for the research Btw the symptoms of #DrTrevorBachmeyer #fitness #gymtok #workoutmotivation #fitnesstips #healthylifestyle #motivationdaily #fittok
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr Trevor Bachmeyer, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.